Author: Chen Dong; Ling Ni; Fang Ye; Meng-Li Chen; Yu Feng; Yong-Qiang Deng; Hui Zhao; Peng Wei; Jiwan Ge; Xiaoli Li; Lin Sun; Pengzhi Wang; Peng Liang; Han Guo; Xinquan Wang; Cheng-Feng Qin; Fang Chen
Title: Characterization of anti-viral immunity in recovered individuals infected by SARS-CoV-2 Document date: 2020_3_20
ID: dptgg05n_8
Snippet: To explore cellular immune responses to SARS-CoV-2, we isolated PBMCs from the whole blood and phenotypically analyzed them by flow cytometry (Figure 2A ). We found that compared to discharged patients, there was a trend towards an increased frequency of NK cells in the follow-up patients ( Figure S2 ). However, there was no significant difference in terms of the percentages of T cells among those two groups and the healthy donors......
Document: To explore cellular immune responses to SARS-CoV-2, we isolated PBMCs from the whole blood and phenotypically analyzed them by flow cytometry (Figure 2A ). We found that compared to discharged patients, there was a trend towards an increased frequency of NK cells in the follow-up patients ( Figure S2 ). However, there was no significant difference in terms of the percentages of T cells among those two groups and the healthy donors.
Search related documents:
Co phrase search for related documents- cellular SARS immune response and flow cytometry: 1, 2, 3, 4, 5, 6, 7
- cellular SARS immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- cellular SARS immune response and SARS immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
- cellular SARS immune response and significant difference: 1
- discharge patient and follow patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- discharge patient and immune response: 1, 2, 3, 4
- discharge patient and significant difference: 1, 2, 3, 4, 5, 6, 7
- flow cytometry and follow patient: 1, 2, 3
- flow cytometry and healthy donor: 1, 2, 3, 4, 5, 6, 7
- flow cytometry and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- flow cytometry and increase frequency: 1, 2, 3
- flow cytometry and NK cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50
- flow cytometry and PBMCs isolate: 1
- flow cytometry and SARS immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- flow cytometry and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- follow patient and healthy donor: 1
- follow patient and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9
- follow patient and SARS immune response: 1, 2, 3, 4
- follow patient and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
Co phrase search for related documents, hyperlinks ordered by date